NEURONETICS, INC.

(STIM)
  Report
Delayed Nasdaq  -  04:00 2022-08-08 pm EDT
4.270 USD   -8.37%
03:46aNeuronetics Files $125 Million Mixed Shelf
MT
08/05Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NEURONETICS, INC.
03:46aNeuronetics Files $125 Million Mixed Shelf
MT
08/05Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02TRANSCRIPT : Neuronetics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02NEURONETICS : Q2 Earnings Snapshot
AQ
08/02Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.3M
MT
08/02NEURONETICS : Supplemental Financial and Operating Information
PU
08/02NEURONETICS : STIM Corporate Presentation August 2022
PU
08/02Neuronetics Reports Second Quarter 2022 Financial and Operating Results
AQ
08/02Neuronetics, Inc. Provides Earnings Guidance for the Quarter Ending September 30, 2022 ..
CI
08/02NEURONETICS : Reports Second Quarter 2022 Financial and Operating Results - Form 8-K
PU
08/02Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended ..
CI
07/28Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
AQ
07/25Neuronetics Agrees to Supply Transcranial Magnetic Stimulation Systems to Alleviant Hea..
MT
07/25Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
GL
07/25Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
AQ
More most relevant news
All news about NEURONETICS, INC.
03:46aNeuronetics Files $125 Million Mixed Shelf
MT
08/05Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/02TRANSCRIPT : Neuronetics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02NEURONETICS : Q2 Earnings Snapshot
AQ
08/02Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.3M
MT
08/02NEURONETICS : Supplemental Financial and Operating Information
PU
08/02NEURONETICS : STIM Corporate Presentation August 2022
PU
08/02Neuronetics Reports Second Quarter 2022 Financial and Operating Results
AQ
08/02Neuronetics, Inc. Provides Earnings Guidance for the Quarter Ending September 30, 2022 ..
CI
More news
News in other languages on NEURONETICS, INC.
03:46aNeuronetics dépose un dossier mixte de 125 millions de dollars
08/02Earnings Flash (STIM) NEURONETICS annonce un chiffre d'affaires de 16,3 millions de dol..
08/02Neuronetics, Inc. fournit des prévisions de bénéfices pour le trimestre se terminant le..
08/02Neuronetics, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos ..
07/25Neuronetics accepte de fournir des systèmes de stimulation magnétique transcrânienne à ..
07/25Neuronetics et Alleviant Health Centers annoncent un partenariat exclusif
07/19VENTE D'INITIÉS : Neuronetics
07/19Neuronetics obtient le feu vert de la FDA pour un système de stimulation magnétique des..
07/19Neuronetics déclare que la FDA autorise le système de stimulation magnétique pour trait..
07/19Neurostics Inc. reçoit l'autorisation de la Food and Drug Administration des États-Unis..
More news
Analyst Recommendations on NEURONETICS, INC.
01/03Piper Sandler Adjusts Neuronetics' Price Target to $9 From $10, Reiterates Overweight R..
MT
2021NEURONETICS : JMP Securities Adjusts Price Target on Neuronetics to $12 From $18, Maintain..
MT
2021NEURONETICS : William Blair Downgrades Neuronetics to Market Perform From Outperform
MT
2021NEURONETICS : BTIG Downgrades Neuronetics to Neutral from Buy
MT
2021NEURONETICS : William Blair Upgrades Neuronetics to Outperform From Market Perform
MT
More recommendations
Press releases
08/05Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/02NEURONETICS : Q2 Earnings Snapshot
AQ
08/02NEURONETICS : Supplemental Financial and Operating Information
PU
08/02NEURONETICS : STIM Corporate Presentation August 2022
PU
More press releases
Upcoming event on NEURONETICS, INC.